Promising drug is victim of bad business

MeSH terms

• Antibodies, Monoclonal / economics*
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / economics
• Antineoplastic Agents / therapeutic use
• Camptothecin / analogs & derivatives*
• Camptothecin / therapeutic use
• Cetuximab
• Clinical Trials as Topic
• Colonic Neoplasms / drug therapy*
• Drug Approval
• Drug Industry / economics
• Drug Industry / legislation & jurisprudence
• ErbB Receptors / antagonists & inhibitors
• Humans
• Irinotecan
• Patents as Topic
• Recombinant Fusion Proteins / economics
• Recombinant Fusion Proteins / therapeutic use
• United States
• United States Food and Drug Administration